DK0641195T3 - Fremgangsmåde til fremstilling af lægemiddelblandinger med forsinket virkning - Google Patents

Fremgangsmåde til fremstilling af lægemiddelblandinger med forsinket virkning

Info

Publication number
DK0641195T3
DK0641195T3 DK93912763.5T DK93912763T DK0641195T3 DK 0641195 T3 DK0641195 T3 DK 0641195T3 DK 93912763 T DK93912763 T DK 93912763T DK 0641195 T3 DK0641195 T3 DK 0641195T3
Authority
DK
Denmark
Prior art keywords
pct
delayed
preparation
sec
date
Prior art date
Application number
DK93912763.5T
Other languages
Danish (da)
English (en)
Inventor
Roland Rauchfuss
Original Assignee
Goedecke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Goedecke Ag filed Critical Goedecke Ag
Application granted granted Critical
Publication of DK0641195T3 publication Critical patent/DK0641195T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
DK93912763.5T 1992-05-22 1993-05-21 Fremgangsmåde til fremstilling af lægemiddelblandinger med forsinket virkning DK0641195T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4216948 1992-05-22

Publications (1)

Publication Number Publication Date
DK0641195T3 true DK0641195T3 (da) 1996-08-05

Family

ID=6459487

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93912763.5T DK0641195T3 (da) 1992-05-22 1993-05-21 Fremgangsmåde til fremstilling af lægemiddelblandinger med forsinket virkning

Country Status (11)

Country Link
US (1) US5792474A (fi)
EP (1) EP0641195B1 (fi)
AT (1) ATE136459T1 (fi)
AU (1) AU4316393A (fi)
DE (1) DE59302200D1 (fi)
DK (1) DK0641195T3 (fi)
ES (1) ES2086229T3 (fi)
FI (1) FI110233B (fi)
GR (1) GR3019734T3 (fi)
HK (1) HK1005307A1 (fi)
WO (1) WO1993024110A1 (fi)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19522899C1 (de) * 1995-06-23 1996-12-19 Hexal Pharmaforschung Gmbh Verfahren zum kontinuierlichen Ersintern eines Granulats
DE19705538C1 (de) * 1997-02-14 1998-08-27 Goedecke Ag Verfahren zur Trennung von Wirkstoffen in festen pharmazeutischen Zubereitungen
US7776314B2 (en) * 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
JP4783278B2 (ja) * 2003-02-03 2011-09-28 ノバルティス アーゲー 医薬製剤
US20070048228A1 (en) 2003-08-06 2007-03-01 Elisabeth Arkenau-Maric Abuse-proofed dosage form
US8075872B2 (en) 2003-08-06 2011-12-13 Gruenenthal Gmbh Abuse-proofed dosage form
DE102005005446A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
DE102004032051A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
DE10336400A1 (de) 2003-08-06 2005-03-24 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
DE10361596A1 (de) 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
RU2006119453A (ru) * 2003-12-04 2007-12-20 Пфайзер Продактс Инк. (Us) Получение посредством основанных на применении жидкостей способов лекарственные формы азитромицина с большим количеством частиц
US6984403B2 (en) * 2003-12-04 2006-01-10 Pfizer Inc. Azithromycin dosage forms with reduced side effects
WO2005053656A1 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Spray-congeal process using an extruder for preparing multiparticulate crystalline drug compositions containing preferably a poloxamer and a glyceride
WO2005053652A1 (en) 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate crystalline drug compositions containing a poloxamer and a glyceride
WO2005053639A2 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Controlled release multiparticulates formed with dissolution enhancers
WO2005053651A1 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate compositions with improved stability
CA2547773A1 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Spray-congeal process using an extruder for preparing multiparticulate azithromycin compositions containing preferably a poloxamer and a glyceride
WO2005053655A1 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Method for making pharmaceutical multiparticulates
DE102004032049A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Gegen Missbrauch gesicherte, orale Darreichungsform
DE102005005449A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
DE102007011485A1 (de) 2007-03-07 2008-09-11 Grünenthal GmbH Darreichungsform mit erschwertem Missbrauch
US20110059140A1 (en) * 2007-12-21 2011-03-10 Gerhard Winter Extruded rod-shaped devices for controlled release of biological substances to humans and animals
TWI454288B (zh) 2008-01-25 2014-10-01 Gruenenthal Chemie 藥物劑型
SI2273983T1 (sl) 2008-05-09 2016-11-30 Gruenenthal Gmbh Postopek za pripravo intermediatne praškaste formulacije in končne trdne odmerne oblike z uporabo stopnje strjevanja z razprševanjem
JP5667183B2 (ja) 2009-07-22 2015-02-12 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 加熱溶融押出成型した制御放出性投与剤型
JP2012533585A (ja) 2009-07-22 2012-12-27 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 酸化感受性オピオイドのための不正使用防止剤形
US9579285B2 (en) 2010-02-03 2017-02-28 Gruenenthal Gmbh Preparation of a powdery pharmaceutical composition by means of an extruder
ES2486791T3 (es) 2010-09-02 2014-08-19 Grünenthal GmbH Forma de dosificación resistente a la manipulación que comprende una sal inorgánica
US9636303B2 (en) 2010-09-02 2017-05-02 Gruenenthal Gmbh Tamper resistant dosage form comprising an anionic polymer
AR087360A1 (es) 2011-07-29 2014-03-19 Gruenenthal Gmbh Tableta a prueba de manipulacion que proporciona liberacion de farmaco inmediato
US20130028972A1 (en) 2011-07-29 2013-01-31 Grunenthal Gmbh Tamper-resistant tablet providing immediate drug release
BR112014019988A8 (pt) 2012-02-28 2017-07-11 Gruenenthal Gmbh Forma de dosagem resistente a socamento compreendendo um composto farmacologicamente ativo e um polímero aniônico
ES2692944T3 (es) 2012-04-18 2018-12-05 Grünenthal GmbH Forma de dosificación farmacéutica resistente a la manipulación y resistente a la descarga rápida de la dosis
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
BR112015026549A2 (pt) 2013-05-29 2017-07-25 Gruenenthal Gmbh forma de dosagem à prova de violação contendo uma ou mais partículas
WO2014191396A1 (en) 2013-05-29 2014-12-04 Grünenthal GmbH Tamper resistant dosage form with bimodal release profile
CN105682643B (zh) 2013-07-12 2019-12-13 格吕伦塔尔有限公司 含有乙烯-醋酸乙烯酯聚合物的防篡改剂型
CA2931553C (en) 2013-11-26 2022-01-18 Grunenthal Gmbh Preparation of a powdery pharmaceutical composition by means of cryo-milling
AU2015261060A1 (en) 2014-05-12 2016-11-03 Grunenthal Gmbh Tamper resistant immediate release capsule formulation comprising Tapentadol
AU2015266117A1 (en) 2014-05-26 2016-11-24 Grunenthal Gmbh Multiparticles safeguarded against ethanolic dose-dumping
MX2017013637A (es) 2015-04-24 2018-03-08 Gruenenthal Gmbh Forma de dosificacion resistente a alteraciones con liberacion inmediata y resistencia contra la extraccion por solventes.
US10842750B2 (en) 2015-09-10 2020-11-24 Grünenthal GmbH Protecting oral overdose with abuse deterrent immediate release formulations
EP3492070A1 (en) * 2017-11-30 2019-06-05 BIT Pharma GmbH Process and device for preparing a solid dispersion

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3013839A1 (de) * 1979-04-13 1980-10-30 Freunt Ind Co Ltd Verfahren zur herstellung einer aktivierten pharmazeutischen zusammensetzung
DE3024416C2 (de) * 1980-06-28 1982-04-15 Gödecke AG, 1000 Berlin Verfahren zur Herstellung von Arzneimitteln mit retardierter Wirkstoff-Freisetzung
FR2581541B1 (fr) * 1985-05-09 1988-05-20 Rhone Poulenc Sante Nouvelles compositions pharmaceutiques permettant la liberation prolongee d'un principe actif et leur procede de preparation
US5518730A (en) * 1992-06-03 1996-05-21 Fuisz Technologies Ltd. Biodegradable controlled release flash flow melt-spun delivery system

Also Published As

Publication number Publication date
EP0641195A1 (de) 1995-03-08
GR3019734T3 (en) 1996-07-31
EP0641195B1 (de) 1996-04-10
FI945465A (fi) 1994-11-21
ATE136459T1 (de) 1996-04-15
WO1993024110A1 (de) 1993-12-09
US5792474A (en) 1998-08-11
DE59302200D1 (de) 1996-05-15
AU4316393A (en) 1993-12-30
FI110233B (fi) 2002-12-31
ES2086229T3 (es) 1996-06-16
HK1005307A1 (en) 1998-12-31
FI945465A0 (fi) 1994-11-21

Similar Documents

Publication Publication Date Title
DK0641195T3 (da) Fremgangsmåde til fremstilling af lægemiddelblandinger med forsinket virkning
DE69326163T2 (de) Verfahren zur herstellung von arzneiformen und kontrollierte freigabe und die soerhaltenen arzneiformen
DE3562555D1 (en) Galenical form for oral administration and its method of preparation by lyophilization of an oil-in-water emulsion
HUP9802996A2 (hu) Eljárás többrétegű, szilárd gyógyszerformák előállítására orális vagy rektális beadásra
KR0166599B1 (ko) 활성성분 방출이 지연되는 용매없는 경구투여약제 조성물 및 상기 조성물의 제조방법
FI905781A (fi) Menetelmä farmaseuttisten koostumusten valmistamiseksi, jotka sisältävät sokerialkoholia ja homogeenisesti dispergoituna hiukkasmaista aktiivista yhdistettä
NO175620C (no) Fremgangsmåte for fremstilling av et antitumorvirksomt legemiddel
ES2108371T3 (es) Nuevos derivados de estradieno de 11-benzaldoxima, procedimientos para su produccion y farmacos conteniendo estos compuestos.
DK1173265T3 (da) Apparat og fremgangsmåde til krystallisation med ultralydstråler
ES2143089T3 (es) Procedimiento para la fabricacion de pildoras con recubrimiento.
HUT49113A (en) Process for producing 2-/2-hydroxy-3-phenoxy-propyl-amino/-ethyl-phenoxy-methyl-amido derivatives and pharmaceutical compositions containing them as active components
OA09528A (fr) Nouveaux dérivés N-substitues de la quinoléine leur procédé de préparation les nouveaux intermédiaires obtenus leur application à titre de médicaments et les compositions pharmaceutiques les renfermant
HUP0002121A2 (hu) Eljárás flurbiprofen gyógypasztillák előállítására
US4143156A (en) Analgetic ester compounds, compositions and method of use
NZ337584A (en) Preparing a glass-like plastic mass from sweetening agents in charging, melting and vacuum zones of an extruder
PT999828E (pt) Processo para a producao de preparacoes de substancia activa com libertacao controlada a partir de uma matriz
US3474107A (en) N-aromatic substituted acid amides
NO173444C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 4-(4'- fluorfenyl-)-tienopyridin-derivater
DK287982A (da) Fremgangsmaade til tidsstyring af frigoerelsen af aktive stoffer fra midler med indhold deraf navnlig fra farmaceutiske praeparater
FR2623501B1 (fr) Nouveaux derives substitues de 20,21-dinoreburnamenine, leur procede de preparation et les nouveaux intermediaires ainsi obtenus, leur application comme medicaments et les compositions pharmaceutiques les renfermant
Burger et al. Domino reactions with fluorinated five-membered heterocycles–syntheses of trifluoromethyl substituted butenolides and γ-ketoacids
FR2705570B1 (fr) Nouvelle formulation d'aérosol médicamentaux à base de fusafungine, son procédé de préparation et les compositions pharmaceutiques qui la contiennent.
JPH09183764A (ja) Ｎ−ベンゾイルプロリンエステル誘導体
MX9700821A (es) Nueva utilizacion y derivados novedosos del imidazol, su procedimiento de preparacion, los nuevos intermediarios obtenidos, su aplicacion a manera de medicamentos y las composiciones farmaceuticas que los incluyen.
AU4398000A (en) A process for the microencapsulation of medicaments